Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome
- 1 February 1999
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 71 (2) , 287-293
- https://doi.org/10.1016/s0015-0282(98)00447-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovariesFertility and Sterility, 1998
- Severe ovarian hyperstimulation syndromeCurrent Opinion in Obstetrics and Gynecology, 1997
- Endocrinology: Ovarian hyperstimulation syndrome with low oestradiol in non-classical 17 -hydroxylase, 17,20-lyase deficiency: what is the role of oestrogens?Human Reproduction, 1996
- Diagnosis, prevention and management of ovarian hyperstimulation syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndromeThe Lancet, 1994
- Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.Journal of Clinical Investigation, 1993
- Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for preventionFertility and Sterility, 1990
- Ovarian Hyperstimulation SyndromeObstetrical & Gynecological Survey, 1989
- Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndromeFertility and Sterility, 1987
- MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONEThe Lancet, 1985